peptides
Bremelanotide, Vyleesi, Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH, CAS: 189691-06-3PT-141
A 7-amino acid cyclic peptide analog of alpha-MSH that activates melanocortin receptors MC3R and MC4R, FDA-approved for hypoactive sexual desire disorder and studied for sexual function in clinical research. Premium Research Peptide.
Dosage
Quantity
Free Shipping
on orders over $100
Shipment Protection
Covers lost or damaged packages
CoA Included
third party tested
Select Size
Kits
$150.00/kit
$150.00
Bremelanotide (PT-141) for hypoactive sexual desire disorder in women
Obstetrics & Gynecology, 2019
Melanocortin receptor agonists and sexual function
Pharmacology Biochemistry and Behavior, 2009
PT-141 intranasal administration improves erectile dysfunction in men
Journal of Sexual Medicine, 2007
* All references are for research and informational purposes only. Not intended as medical advice.
Customer Reviews
No reviews yet. Be the first to review!
Frequently researched together
⚠ Research Use Only — Not for Human Consumption
This product is sold strictly for laboratory and research purposes only. It is not intended for human or animal consumption, diagnostic use, or therapeutic applications. By purchasing, you confirm that you are a licensed researcher or scientist and that this product will be used solely for in vitro research. These statements have not been evaluated by the FDA. This product is not a drug, food, or cosmetic and may not be misbranded, misused, or mislabeled as such.